Long-term Monocyte Dysfunction After Sepsis in Humanized Mice Is Related to Persisted Activation of Macrophage-Colony Stimulation Factor (M-CSF) and Demethylation of PU.1, and It Can Be Reversed by Blocking M-CSF or by Transplanting Naïve...
Overview
Authors
Affiliations
The duration of post-sepsis long-term immune suppression is poorly understood. Here, we focused on the role of monocytes (MO) as the pivotal cells for long-term regulation of post-sepsis milieu. Lost ability of MO to adapt is seen in several acute conditions, but it is unclear for how long MO aberrancy post-sepsis can persist. Interestingly, the positive feedback loop sustaining secretion of macrophage-colony stimulation factor (M-CSF) can persist even after resolution of sepsis and significantly alters performance of MO. Here, we investigated the activation of M-CSF, and it as critical regulator of PU.1 in mice surviving 28 days after sepsis. Our primary readout was the ability of MO to differentiate into dendritic cells (DCs; MO→iDC) since this is one of the critical processes regulating a successful transition from innate to acquired immunity. We utilized a survival modification of the cecal ligation and puncture (CLP) model of sepsis in humanized mice. Animals were sacrificed 28 days after CLP (t). Untouched (CONTR) or sham-operated (SHAM) animals served as controls. Some animals received rescue from stem cells originally used for grafting 2 weeks after CLP. We found profound decrease of MO→iDC in the humanized mice 28 days after sepsis, demonstrated by depressed expression of CD1a, CD83, and CD209, diminished production of IL-12p70, and depressed ability to stimulate T cells in mice after CLP as compared to SHAM or CONTR. defect in MO→iDC was accompanied by decrease of BDCA-3 endogenous circulating DC. Interestingly, post-CLP MO had persistent activation of M-CSF pathway, shown by exaggerated secretion of M-CSF, activation of PU.1, and demethylation of . Neutralization of the M-CSF reversed the post-CLP MO→iDC aberration. Furthermore, transplantation of naïve, autologous stem cell-derived MO restored CLP-deteriorated ability of MO to become DC, measured as recovery of CD1a expression, enhanced production of IL-12p70, and ability of IL-4 and GM-CSF MO to stimulate allogeneic T cells. Our results suggest the role of epigenetic mediated M-CSF aberration in mediating post-sepsis immune system recovery.
Immunotherapy in the context of sepsis-induced immunological dysregulation.
Wu Y, Wang L, Li Y, Cao Y, Wang M, Deng Z Front Immunol. 2024; 15:1391395.
PMID: 38835773 PMC: 11148279. DOI: 10.3389/fimmu.2024.1391395.
Gonzalez H, McCarthy S, Masterson C, Byrnes D, Sallent I, Horan E Stem Cell Res Ther. 2023; 14(1):151.
PMID: 37280647 PMC: 10245544. DOI: 10.1186/s13287-023-03385-6.
Immunopathology of chronic critical illness in sepsis survivors: Role of abnormal myelopoiesis.
Rincon J, Efron P, Moldawer L J Leukoc Biol. 2022; 112(6):1525-1534.
PMID: 36193662 PMC: 9701155. DOI: 10.1002/JLB.4MR0922-690RR.
Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis.
Wang N, Lu Y, Zheng J, Liu X Front Immunol. 2022; 13:956448.
PMID: 35990662 PMC: 9388785. DOI: 10.3389/fimmu.2022.956448.
Tuerxun K, Midtbo K, Sarndahl E, Vorontsov E, Karlsson R, Persson A J Leukoc Biol. 2022; 112(4):679-692.
PMID: 35285058 PMC: 9790682. DOI: 10.1002/JLB.3A0421-216R.